# A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men

> **NCT06649630** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 95 (actual)

## Conditions studied

- Haemophilia A

## Interventions

- **DRUG:** NNC0442-0344 A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06649630
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-23
- **Primary completion:** 2026-03-26
- **Final completion:** 2026-03-26
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06649630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06649630, "A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06649630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*